Evaxion Biotech Earnings Estimate

By analyzing Evaxion Biotech's earnings estimates, investors can diagnose different trends across Evaxion Biotech's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Evaxion Biotech AS is based on EPS before non-recurring items and includes expenses related to employee stock options. Evaxion Biotech is projected to generate -0.3275 in earnings per share on the 31st of December 2024. Evaxion Biotech earnings estimates module stress-tests analyst consensus about projected Evaxion Biotech AS EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Evaxion Biotech, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Evaxion Biotech's earnings estimates, investors can diagnose different trends across Evaxion Biotech's analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to rise to about 76.5 K in 2024, whereas Pretax Profit Margin is likely to drop (296.64) in 2024. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.